Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARINA-1 in Patients With a Tracheostomy
NCT05658029Phase 1Withdrawn
- Start
- May 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ARINA-1 in tracheostomy. Primary endpoint: Incidence of adverse events / serious adverse events at 28 days. Planned start May 2023; status: withdrawn.
02
Drugs
ARINA-1
03
Conditions
tracheostomy
Beyond the preview
Go deeper on NCT05658029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05658029.